Skip to content
  • CAT
  • ESP
  • ENG
  • About us
  • Contact
El·lipse
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • Research
  • Public engagement
  • Scientific life
  • Community
  • About us
  • Contact
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
  • CAT
  • ESP
  • ENG

Research

Understanding how environmental information is converted into molecular information in sperm RNAs, and then transmit across generations, is the next exciting and unanswered question for this CRG team.
28.05.2020

New therapeutic targets for infertility and cancer revealed

Txema's drawing.
27.05.2020

Chimps and gorillas’ genomes could help better understand human tumours

25.05.2020

Formation of epithelial-like structures in single-celled organisms

The last "IMIM Seminars At Home" presented two of the Covid19 projects taking place at the IMIM. One focuses on drug development, the other relies on the immune response.
22.05.2020

Drugs and antibodies: the strategies of two IMIM groups to block SARS-CoV-2

Ivermectin was recently shown to inhibit the replication of SARS-CoV-2 in vitro at very high doses, but this effect has not yet been studied in vivo. The new study will investigate this question in a randomised trial. | Picture by ISGlobal.
21.05.2020

New study to assess the efficacy of ivermectin against COVID-19

Researchers used light exposure to impress a complex pattern, spread across an area slightly smaller than the thickness of a human hair, onto a biofilm community, made up of hundreds of individual bacteria. | Picture by the UPF and UCSD.
19.05.2020

DCEXS-UPF researchers show bacteria can store information in a similar way to neurons

Male lion at the Copenhagen Zoo in April 2014. | Picture by Ross Barnett, researcher at the GLOBE Institute and co-author of the study.
18.05.2020

Researchers analyze the evolutionary history of the lion, key to its conservation in the future

Untrained staff performing the test will get an unequivocal result from the instrument. | Picture by the UPF.
15.05.2020

InstaCOVID19: UPF develops rapid diagnostic tests for SARS-CoV-2

So far, two recent studies suggest that hydroxychloroquine may be effective in reducing the viral load of SARS-CoV-2, although the results are inconclusive and further research is needed.
13.05.2020

New study to assess the efficacy of hydroxychloroquine in the prevention and treatment of COVID-19 during pregnancy

13.05.2020

Memory alterations described in mice with Down syndrome

Patients who received redemsivir had a 31% faster recovery time than those who received placebo. There was a 4-day reduction in hospital stay. | Picture by Francisco Avia.
08.05.2020

The antiviral drug remdesivir reduces the time to recovery in COVID-19 patients

The developed tool, which is at the implementation phase, uses Artificial Intelligence technology to assist the diagnosis of COVID-19. | Picture by Geralt from Pixabay.
07.05.2020

Artificial Intelligence, a great ally in the diagnosis of COVID-19

El·lipse is published by the PRBB Communications and Corporate Relations Area.

Dr Aiguader, 88, 08003 Barcelona, Spain

For any suggestions or collaborations please contact us at ellipse@prbb.org

  • Read past print editions
  • About El·lipse
  • About the PRBB
  • Legal disclaimer
  • instagram
  • twitter
  • flickr
  • linkdin
  • facebook
  • youtube
© 2026 El·lipse, PRBB
  • Home
  • News
  • Our picks
This website uses cookies that provide us with personal information, such as data associated with your browsing. If you click on I AGREE, both we and our Partners can install cookies or access non-sensitive information on your device in order to facilitate the reproduction of content, provide features on social networks, create profiles and compile statistics on traffic and usability in our website. You can get MORE INFORMATION by accessing our COOKIES POLICY. I agree More information
Privacy & Cookies Policy
Necessary Always Enabled

Subscribe to our mailing list
Want to be the first to know everything that goes on at the biggest biomedical research hub in Southern Europe? Subscribe to the el·lipse newsletter!

We will send you an email with the latest news.

See you soon!

*Required field

Field is not valid
You have to authorize data treatment

At any time, you can exercise the rights of access, rectification, opposition, portability, limitation to treatment and deletion of the data subject to treatment by clicking on the links "Update data" and "Unsubscribe", sending a letter indicating the right exercised to the postal address indicated at the bottom or to the following email address ellipse@prbb.org